Viral infection treatment with 5-aminolevulinic acid
A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereo...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses. |
---|---|
Bibliography: | Application Number: US202117340064 |